Liver fibrosis with persistently normal alanine transaminase levels exhibits a distinct treatment response in MASLD
MASLD patients with liver fibrosis and persistently normal ALT levels exhibited a less favourable treatment response to fibrosis than those with elevated ALT levels, necessitating more substantial reductions in steatosis and weight to achieve the desired outcomes.
Authors
- Congxiang Shao (ORCID: https://orcid.org/0000-0001-9628-6426)
- Shuyu Zhuo (ORCID: https://orcid.org/0000-0002-2306-7174)
- Junzhao Ye (ORCID: https://orcid.org/0000-0003-3163-4164)
- Bihui Zhong (ORCID: https://orcid.org/0000-0002-4638-7699)
- Teng Long (ORCID: https://orcid.org/0000-0002-2380-9502)
- Zhi Dong
- Wei J. Wang (ORCID: https://orcid.org/0000-0002-4848-7394)
- Ling Luo (ORCID: https://orcid.org/0000-0002-7924-415X)
Institutions
- Sun Yat-sen University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- BMJ Open Gastroenterology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1136/bmjgast-2025-001895
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- National Natural Science Foundation of China
- Sun Yat-sen University
- Natural Science Foundation of Guangdong Province